Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity

Hsuan-An Chen1,2, Yu-Jui Ho1, Riccardo Mezzadra1

  • 1Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer Discovery
|October 27, 2022
PubMed

Insights

Cellular senescence enhances tumor cell visibility to the immune system by altering cell surface receptors and improving environmental sensing. This improves immune clearance of senescent cells, crucial for cancer rejection.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Cellular senescence is a state of stable cell-cycle arrest.
  • Senescence is often accompanied by a secretory program that can aid immune clearance.
  • Senescence can trigger CD8 T cell-mediated tumor rejection in liver cancer models.

Discussion:

  • Senescence remodels the cell-surface proteome, altering how tumor cells sense environmental factors like type II interferon (IFNγ).
  • Senescent cells upregulate the IFNγ receptor, becoming hypersensitive to IFNγ and enhancing antigen-presenting machinery.
  • These changes are also observed in human tumor cells experiencing therapy-induced senescence.

Key Insights:

  • Disrupting IFNγ sensing in senescent cells impairs their immune clearance without affecting the senescence state or secretory program.
  • Senescent cells exhibit enhanced abilities in both sending and receiving environmental signals.
  • Both signal sending and receiving are essential for effective immune surveillance of senescent cells.

Outlook:

  • Senescence engages interplay between tissue remodeling and sensing programs to increase tumor cell visibility to the adaptive immune system.
  • This facet of senescence establishes reciprocal signaling interactions that can be therapeutically induced to boost antitumor immunity.
  • Further research can explore therapeutic strategies targeting these senescence-induced signaling pathways for cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K